Utility of serum complement factors C3 and C4 as biomarkers during therapeutic management of giant cell arteritis
Sign Up to like & getrecommendations! Published in 2022 at "Scandinavian Journal of Rheumatology"
DOI: 10.1080/03009742.2022.2047311
Abstract: Objective There is a strong unmet need for biomarkers in giant cell arteritis (GCA), as C-reactive protein (CRP) may be unreliable in patients treated with Tocilizumab (TCZ). We aimed to assess whether C3 and C4… read more here.
Keywords: utility serum; serum complement; giant cell; cell arteritis ... See more keywords
Utility of serum Galactomannan in diagnosing COVID-19 patients with suspected IPA: an observational study in resource limited settings.
Sign Up to like & getrecommendations! Published in 2022 at "European review for medical and pharmacological sciences"
DOI: 10.26355/eurrev_202201_27897
Abstract: OBJECTIVE To study the utility of Galactomannan (GM) antigen as a screening marker for diagnosing invasive pulmonary aspergillosis (IPA) in coronavirus disease 2019 (COVID-19) patients. PATIENTS AND METHODS The serum samples from patients with severe… read more here.
Keywords: study; galactomannan; patients median; covid patients ... See more keywords